SCHEMBL23889040

SCHEMBL23889040

CC(=O)c1cnn2c(CCC(F)(F)F)c(OCCC(F)(F)F)ccc12

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SLC6A9 P48067 1/20 0.35
▸ ROCK2 O75116 2/20 0.35
▸ SCN8A Q9UQD0 2/20 0.34
▸ SCN10A Q9Y5Y9 2/20 0.34
▸ EPHX2 P34913 4/20 0.33
▸ ACACB O00763 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ PLAT P00750 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ NR2F2 P24468 1/20 0.32
▸ PTGDR2 Q9Y5Y4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19128038 0.89 EPHX2 (0.35) SLC6A9ROCK2SCN8ASCN10AEPHX2
SCHEMBL20646954 0.88 LMNA (0.38) KDM4EALDH1A1TDP1SMN1; SMN2LMNA
SCHEMBL20646868 0.88 SLC6A9 (0.34) SLC6A9ROCK2EPHX2ACACBPLAT
SCHEMBL20647111 0.88 CNR2 (0.39) ROCK2
SCHEMBL19150259 0.81 ALDH1A1 (0.36) KDM4EALDH1A1TDP1SMN1; SMN2KMT2A
SCHEMBL23889037 0.81 ROCK2 (0.41) ROCK2PLAT
SCHEMBL19150600 0.80 MAPT (0.33) SLC6A9ROCK2ALDH1A1
SCHEMBL19128573 0.79 CNR2 (0.39) ROCK2KDM4ELMNAKMT2A
SCHEMBL19128175 0.79 KDM4E (0.45) KDM4EALDH1A1TDP1SMN1; SMN2LMNA
SCHEMBL23889014 0.78 ROCK2 (0.43) ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3954681-A1 SPIROHEPTANE SALICYLAMIDES AND RELATED COMPOUNDS AS INHIBITORS OF ROCK Bristol-Myers Squibb Company (US) 2022-02-16 — — EP disclosed
EP-3402790-B1 SPIROHEPTANE SALICYLAMIDES AND RELATED COMPOUNDS AS INHIBITORS OF ROCK BRISTOL MYERS SQUIBB CO (US) 2021-10-06 — — EP disclosed
Send feedback